Ventas, Inc. (VTR)
NYSE$66.36
Market Cap
$29.01B
Sector
Real Estate
Industry
REIT—Healthcare Facilities
Rank in Sector
177 of 179
Rank in Industry
9 of 10
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
VTR Insider Trading Activity
VTR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $45,818,111 | 30 | 100 |
Related Transactions
| RAKOWICH WALTER C | director | 0 | $0 | 1 | $103,814 | $-103,814 |
| Liebbe Gregory R | SVP, Chief Accounting Officer | 0 | $0 | 2 | $941,211 | $-941,211 |
| Bulgarelli Peter J. | Pres&CEO-LHS/EVP Office-Ventas | 0 | $0 | 7 | $1.35M | $-1.35M |
| Probst Robert F | EVP and CFO | 0 | $0 | 2 | $2.05M | $-2.05M |
| CAFARO DEBRA A | Chairman and CEO | 0 | $0 | 18 | $41.37M | $-41.37M |
About Ventas, Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: …
Insider Activity of Ventas, Inc.
Over the last 12 months, insiders at Ventas, Inc. have bought $0 and sold $45.82M worth of Ventas, Inc. stock.
On average, over the past 5 years, insiders at Ventas, Inc. have bought $0 and sold $13.61M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $580,101 was made by CROCKER DOUGLAS II (director) on 2013‑12‑10.
List of Insider Buy and Sell Transactions, Ventas, Inc.
| 2025-03-04 | Sale | CAFARO DEBRA A | Chairman and CEO | 1,200 0.0003% | $71.04 | $85,248 | -3.36% | |
| 2025-03-03 | Sale | CAFARO DEBRA A | Chairman and CEO | 388 <0.0001% | $71.00 | $27,548 | -3.94% | |
| 2025-02-28 | Sale | CAFARO DEBRA A | Chairman and CEO | 41,294 0.0095% | $69.08 | $2.85M | -2.12% | |
| 2025-02-25 | Sale | CAFARO DEBRA A | Chairman and CEO | 214,679 0.0507% | $68.22 | $14.64M | +0.09% | |
| 2025-02-24 | Sale | CAFARO DEBRA A | Chairman and CEO | 9,680 0.0023% | $68.00 | $658,277 | +0.58% | |
| 2025-02-13 | Sale | Liebbe Gregory R | SVP, Chief Accounting Officer | 3,866 0.001% | $63.00 | $243,558 | +4.27% | |
| 2024-10-30 | Sale | CAFARO DEBRA A | Chairman and CEO | 34,085 0.0082% | $66.67 | $2.27M | -6.55% | |
| 2024-10-29 | Sale | CAFARO DEBRA A | Chairman and CEO | 121,248 0.0293% | $66.17 | $8.02M | -5.91% | |
| 2024-10-25 | Sale | CAFARO DEBRA A | Chairman and CEO | 6,004 0.0015% | $66.11 | $396,930 | -4.17% | |
| 2024-10-24 | Sale | CAFARO DEBRA A | Chairman and CEO | 74,763 0.0184% | $66.10 | $4.94M | -5.56% | |
| 2024-09-11 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 1,500 0.0004% | $65.27 | $97,905 | -2.28% | |
| 2024-09-10 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 6,000 0.0015% | $64.99 | $389,942 | -1.66% | |
| 2024-09-09 | Sale | CAFARO DEBRA A | Chairman and CEO | 22,690 0.0055% | $63.81 | $1.45M | -0.33% | |
| 2024-09-06 | Sale | CAFARO DEBRA A | Chairman and CEO | 8,154 0.002% | $63.04 | $514,021 | +1.74% | |
| 2024-09-05 | Sale | CAFARO DEBRA A | Chairman and CEO | 6,827 0.0017% | $63.20 | $431,439 | +1.79% | |
| 2024-09-04 | Sale | CAFARO DEBRA A | Chairman and CEO | 3,617 0.0009% | $63.05 | $228,046 | +2.15% | |
| 2024-08-27 | Sale | CAFARO DEBRA A | Chairman and CEO | 38,434 0.0093% | $60.14 | $2.31M | +5.64% | |
| 2024-08-27 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 7,125 0.0017% | $60.16 | $428,610 | +5.64% | |
| 2024-08-26 | Sale | CAFARO DEBRA A | Chairman and CEO | 2,854 0.0007% | $60.02 | $171,286 | +6.38% | |
| 2024-08-26 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 375 <0.0001% | $60.01 | $22,504 | +6.38% |
Total: 306
*Gray background shows transactions not older than one year
Insider Historical Profitability
18.98%
| CROCKER DOUGLAS II | director | 104164 0.0238% | $6.91M | 1 | 4 | +14.31% |
| GILCHRIST RICHARD I | director | 35270 0.0081% | $2.34M | 1 | 1 | +16.32% |
| THEOBALD THOMAS C | director | 16949 0.0039% | $1.12M | 2 | 3 | +22.64% |
Historical Insider Profitability vs. Competitors
$14,028,484 | 72 | 11.64% | $3.35B | |
$31,136,917 | 60 | 12.47% | $10.36B | |
$3,321,013 | 56 | -3.03% | $14.01B | |
$1,800,534 | 28 | 21.53% | $4.01B | |
$60,705,795 | 24 | 8.59% | $579.1M |
VTR Institutional Investors: Active Positions
| Increased Positions | 412 | +55.98% | 36M | +9.03% |
| Decreased Positions | 312 | -42.39% | 14M | -3.61% |
| New Positions | 111 | New | 6M | New |
| Sold Out Positions | 78 | Sold Out | 2M | Sold Out |
| Total Postitions | 836 | +13.59% | 421M | +5.42% |
VTR Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $4.6M | 15.22% | 66.5M | +912,813 | +1.39% | 2024-12-31 |
| Blackrock, Inc. | $3.3M | 10.92% | 47.71M | +2M | +3.71% | 2024-12-31 |
| Jpmorgan Chase & Co | $2.06M | 6.81% | 29.74M | +2M | +7.91% | 2024-12-31 |
| State Street Corp | $1.88M | 6.22% | 27.2M | +526,620 | +1.97% | 2024-12-31 |
| Fmr Llc | $1.52M | 5.01% | 21.9M | -1M | -6.25% | 2024-12-31 |
| Principal Financial Group Inc | $1.29M | 4.27% | 18.64M | -233,630 | -1.24% | 2024-12-31 |
| Apg Asset Management Us Inc. | $805,014.00 | 2.66% | 11.64M | -1M | -9.48% | 2024-12-31 |
| Geode Capital Management, Llc | $757,420.00 | 2.51% | 10.95M | +537,253 | +5.16% | 2024-12-31 |
| Resolution Capital Ltd | $493,825.00 | 1.63% | 7.14M | -2M | -22.03% | 2024-12-31 |
| Centersquare Investment Management Llc | $472,640.00 | 1.56% | 6.83M | -55,511 | -0.81% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.